Jun, 12 2019 15:00 JST

Source: Singapore eDevelopment Ltd

Global BioLife's new mosquito repellent formula performs well against mosquitos in independent testing


SINGAPORE, Jun, 12 2019 - (ACN Newswire) - SGX-listed Singapore eDevelopment Ltd (SeD; SGX:40V) wishes to announce that its U.S. biomedical subsidiary, Global BioLife Inc., has independently tested a new mosquito repellent formula which performs well against mosquitos for six (6) to eight (8) hours.

In 2017, SeD announced a collaboration between Global BioLife and U.S. based Chemia Corporation to develop a suite of fragrances referred to as 3F (Functional Fragrance Formulation). Previous testing was promising for the 3F Mosquito Fragrance, which is made of specialised oils sourced from botanicals that mosquitoes avoid in varying concentrations of 0.25% to 5%.

Global BioLife contracted U.S. based Snell Scientifics, LLC in Meansville, Georgia to conduct a study on the new mosquito repellent formula and the results of the study showed that it repelled between 82% to 95% of mosquitos for six (6) hours after application.

"Utilising fragrances to repel mosquitos with this level of efficacy is a game changer for the consumer products industry," said Mr. Thomas A. Meyer, Chemia's Vice-President of Innovation and Sustainability.

Globally, an estimated 3.4 billion people in 92 countries are at risk of being infected with Zika, Dengue, West Nile Virus, Malaria and other mosquito transmitted diseases. Mosquito repellent products are key in the fight against mosquito transmitted diseases, while a product favoured by consumers is easy to apply, is considered safe, and does not have unpleasant attributes such as a strong chemical odour.

The market for safe mosquito repellents is expanding, and consumers have expressed a demand for effective mosquito repellent products with appealing scents. The most recently tested product has a fragrance that is modeled on the fresh scent of the Ghost Orchid, a rare flower known for its distinctive and pleasant aroma found in the Everglades of Florida.

"3F Mosquito works differently from traditional insect repellents. It's effective even at very low concentrations due to its multi-aspect receptor inhibition," said Mr. Daryl Thompson, Global BioLife's Director of Scientific Initiatives.

"Global BioLife is extremely proud of these test results," said SeD's Executive Chairman Mr. Chan Heng Fai. "3F is an innovative product that works in an entirely different manner from any other product on the market today. 3F is a true success for people everywhere and will help reduce the number of mosquito transmitted diseases on a global scale."

Global BioLife is currently in discussions with interested companies for potential licensing and global deployment of this new mosquito repellent formula.

About Singapore eDevelopment Limited
Incorporated on 9 September 2009 and listed on the Singapore Exchange in July 2010, Singapore eDevelopment Limited is involved in (i) property development and investments primarily in the United States and Western Australia; (ii) information technology-related businesses; (iii) development, research, testing, manufacturing, licensing and distribution of biomedical products; and (iv) investment activities. For more information, please visit: www.SeD.com.sg or email [email protected].

About Global BioLife Inc.
Global BioLife Inc. ("GBLI") is a 70%-held direct subsidiary of Global BioMedical Inc., which is a wholly-owned direct subsidiary of Singapore BioMedical Pte. Ltd., which in turn is a wholly-owned direct subsidiary of Singapore eDevelopment Limited, a company listed on the Singapore Exchange. The remaining shareholding of Global BioLife Inc. is held by Global Research and Discovery Group Scientific LLC ("GRDGS") at 20% and Australian Exchange-listed Holista CollTech Limited ("Holista") at 10%. For more information, please visit: http://www.globalbiolife.com.

About GRDG Sciences, LLC.
GRDG Sciences, LLC is an advanced research team formed in Florida by natural products discovery drug research scientist, Daryl Thompson. For more information, please visit: http://www.globalrdg.com.


Source: Singapore eDevelopment Ltd
Sectors: HealthCare, Cosmetics/Spec.Chem

Copyright ©2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Related Press Release


Global BioLife Inc.'s Naturally Modified Sugar Laetose(TM) Unveiled at Harvard Global Health Summit
July 24 2019 15:00 JST
 
Singapore eDevelopment subsidiary Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis
January 28 2019 12:00 JST
 
Singapore eDevelopment Subsidiary, Global BioLife, Proudly Announces Presentation of Parkinson's Research at Neuroscience 2018
November 07 2018 19:00 JST
 
Singapore eDevelopment Announces Corporate and Business Update
June 18 2018 19:00 JST
 
Singapore Exchange-Listed Singapore eDevelopment Limited's U.S. Biomedical Subsidiary Global BioLife, Inc. Develops Low Glycemic Modified Sugar
May 31 2018 18:00 JST
 
Singapore eDevelopment biomedical subsidiary confirms LB2 efficacy against Ebola
March 01 2018 14:00 JST
 
Singapore eDevelopment's Biomedical Subsidiary Confirms 100% Repellency of 3F Mosquito Fragrance
November 01 2017 18:00 JST
 
SGX-Listed Singapore eDevelopment's Global BioLife Inc Develops Breakthrough Modified Sugar
October 24 2017 18:00 JST
 
Singapore eDevelopment's Global BioLife and U.S.-based Chemia Corporation to Develop Functional Fragrances to Fight Mosquito-Borne Diseases
August 15 2017 19:00 JST
 
First-Year Performance of Global Systematic Multi-Strategy Fund
June 15 2017 10:15 JST
 
More Press release >>

Latest Press Release


More Latest Release >>